Skip to content
Homepage
Clinic directory

4 Best Peptide Therapy Clinics in Boston, Massachusetts

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Boston, MA

Peptide Therapy clinics in Boston

Boston has Harvard-affiliated academic medicine and some of the country's strictest pharmacy oversight after the 2012 NECC outbreak, and peptide therapy has grown into a visible slice of the local wellness market. The clinics we track across Back Bay, Beacon Hill, Cambridge, and Brookline range from physician-led longevity practices to medspa-adjacent wellness offices offering sermorelin blends and growth hormone peptides. Most local prescribers have training or admitting privileges within the Mass General Brigham, BIDMC, and Tufts Medical Center network. The scene here skews toward academic-trained physicians running conservative peptide protocols with rigorous monitoring. The regulatory landscape shifted sharply in 2023 and 2024 when the FDA placed several widely prescribed peptides on its Category 2 bulk substances list, restricting which ingredients compounding pharmacies could legally source. That changed access overnight for BPC-157, CJC-1295, ipamorelin, and thymosin beta-4. Sermorelin and tesamorelin remain FDA-approved for specific indications, and reputable Boston clinics now draw a clearer line between approved peptides and off-label research compounds than they did two years ago.

4 Clinics

MD on staff

Balance HCG Therapy Clinic

Boston, MA

Balance HCG Therapy Clinic, a Peptide & Hormone Optimization clinic in Boston, specializes in hormone-based and peptide-driven protocols for weight management, erectile dysfunction, and testosterone …

  • Peptide Therapy
  • Erectile Dysfunction (ED) Treatment
  • Hormone Replacement Therapy (HRT)
  • Testosterone Replacement Therapy (TRT)

Sound Shapes Med Spa

Boston, MA

Sound Shapes Med Spa, located in Boston, specializes in hormone optimization and peptide therapy alongside regenerative aesthetic treatments. The clinic offers bioidentical hormone replacement therap…

  • PRP Therapy
  • IV Therapy
  • Laser Therapy (LLLT)
  • Acne Treatment
  • Peptide Therapy
MD on staff

Boston Direct Health

Boston, MA

Boston Direct Health, an integrative clinic in Boston, specializes in sexual wellness and regenerative medicine for both men and women. The practice offers exosome therapy, platelet-rich plasma treat…

  • PRP Therapy
  • IV Therapy
  • Laser Therapy (LLLT)
  • Acne Treatment
  • Red Light Therapy

Remedy Place

Boston, MA

Remedy Place Boston, a wellness clinic in Boston, offers hyperbaric oxygen therapy and red-light therapy alongside cryotherapy and infrared sauna for recovery and cellular support. The clinic provide…

  • NAD IV Therapy
  • Vitamin IV Therapy
  • Hyperbaric Oxygen Therapy (HBOT)
  • Cryotherapy
  • Red Light Therapy
15 30 50 results per page

Regulatory context

A note on Massachusetts's peptide therapy rules.

Most research peptides used in regenerative medicine (BPC-157, TB-500, CJC-1295, ipamorelin) are not FDA-approved drugs. Sermorelin and tesamorelin hold FDA approvals for specific indications. The FDA placed several peptides into Category 2 on its Bulk Drug Substances Nominated for Use in Compounding list during 2023 and 2024, limiting 503A sourcing. Section 503A covers traditional compounding pharmacies; Section 503B covers FDA-registered outsourcing facilities held to cGMP.

  • Massachusetts General Laws Chapter 112 Sections 24 through 42A (Pharmacy)
    Governs pharmacy licensure and compounding under the Massachusetts Board of Registration in Pharmacy.
  • 247 CMR 9.00 (Compounding)
    Sets sterile and non-sterile compounding standards consistent with USP 795 and 797, tightened after NECC.
  • Massachusetts General Laws Chapter 112 Section 2 (Physicians)
    Regulates physician practice and delegation.
  • Massachusetts Naturopathic Doctor Practice Act (M.G.L. c. 112 Sec. 270-274)
    Licenses NDs with a limited formulary.

Massachusetts has the strictest compounding oversight in the United States, driven by the 2012 New England Compounding Center (NECC) meningitis outbreak. The Board of Registration in Pharmacy inspects under 247 CMR 9.00 with rigorous sterile compounding requirements. Non-resident pharmacies shipping peptides into Massachusetts must hold a current non-resident permit and undergo state inspection. The Board publishes detailed disciplinary history.

Peptide Therapy in Boston, answered.

Boston clinics most commonly offer sermorelin and sermorelin plus ipamorelin blends for growth hormone support, both of which are FDA-approved for adult GH deficiency. Healing peptides like BPC-157 and thymosin beta-4 (TB-500) are sometimes offered, but neither is FDA-approved and both landed on the FDA's Category 2 bulk list in 2023, which restricts compounding pharmacy sourcing. CJC-1295 and tesamorelin (Egrifta) appear in some protocols; tesamorelin is FDA-approved for HIV-associated lipodystrophy only. Melanotan II, epithalon, and selank are not FDA-approved.

$450 to $700 per month for sermorelin or sermorelin plus ipamorelin blends. $600 to $1,100 per month for BPC-157 plus TB-500 protocols when available through compounding. $550 to $950 per month for peptide plus hormone optimization bundles. Expect $400 to $900 upfront for initial labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) and the intake consult. Most clinics expect a 3 to 6 month commitment with monthly or quarterly follow-ups, and injection supplies and shipping from the compounding pharmacy are usually bundled into the monthly price.

Sermorelin and tesamorelin are FDA-approved for specific indications, so those are the only peptides a Massachusetts clinic can prescribe as standard practice with full FDA backing. BPC-157, CJC-1295, ipamorelin, thymosin beta-4 (TB-500), epithalon, melanotan, and most other research peptides are not FDA-approved. The FDA's 2023-2024 Category 2 bulk substances list decision meant 503A compounding pharmacies lost legal access to many of those ingredients, so availability fluctuates. Any Boston clinic that still offers a long menu of non-approved peptides should disclose exactly where those ingredients come from.

Massachusetts grants nurse practitioners full practice authority, so NPs can evaluate, prescribe, and manage peptide protocols independently. Compounding pharmacy partnership remains required for custom peptide prescriptions, and most clinics work with a 503A pharmacy licensed in the state. The Massachusetts Board of Registration in Medicine licenses physicians and the Massachusetts Board of Pharmacy enforces some of the country's strictest sterile compounding rules following the 2012 NECC meningitis outbreak. Peptides are typically administered by subcutaneous injection at home after a training session at the clinic, though some Boston offices offer in-clinic injections. Be wary of non-clinical operators selling peptides labeled as research chemicals, which is a federal red flag regardless of state law.

Verify the prescribing physician's active license through the Massachusetts medical board and confirm their NPI number through the NPPES registry. Ask which 503A compounding pharmacy supplies the peptides and whether that pharmacy is licensed in Massachusetts. Request baseline labs (CBC, CMP, IGF-1, hormone panel, inflammatory markers) before starting any growth hormone peptide, and confirm a monitoring schedule. Reputable Boston clinics in Back Bay will clearly distinguish FDA-approved peptides from off-label compounds and avoid marketing research chemicals to the public.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology